INsTantenous wavE-Free Ratio-guided PCI Versus Fractional Flow REserve-Guided PCI in rouTine Clinical Practice, Prospective, Multicenter Registry
Condition(s) studied
Investigational drug(s) / intervention(s)
Instantaneous wave-free ratio measurement: Instantaneous wave-free ratio measurement in order to evaluate functional significance of epicardial stenosis
Study summary
The current study sought to evaluate the clinical relevance of iFR-guided strategy in real world clinical practice using unrestricted study population from stable angina to acute coronary syndrome including acute ST-segment elevation myocardial infarction. Previous abundant historical data of FFR-guided strategy will be also included as historical control to validate the iFR-guided strategy.
Eligibility
Primary outcome measure(s)
- Patient-oriented composite outcome (POCO) — at 2-year after index procedure
a composite of any death, any myocardial infarction (MI) or any revascularization according to the ARC consensus
Trial sites (4)
| Facility | City | Region | Status |
|---|---|---|---|
| Keimyung University Dongsan Medical Center | Daegu | South Korea | |
| Inje University Ilsan Paik Hospital | Goyang | South Korea | |
| Samsung Medical Center | Seoul | South Korea | |
| Seoul National University Hospital | Seoul | South Korea |
More Samsung Medical Center trials in South Korea
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03338309 on ClinicalTrials.gov ↗ ← All trials in South Korea